L-glutamine therapy for sickle cell diseases and thalassemia

Details L-glutamine therapy for sickle cell diseases and thalassemia L-glutamine therapy for sickle cell diseases and thalassemia

1996-05-01

1997-12-02

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

A61K 31195

Patent

active

056936710

ABSTRACT:
A method and kit for treating patients suffering from sickle cell disease and thalassemia. The method includes regularly administering a safe and pharmacologically effective amount of L-glutamine based compound to a patient to reduce pain, requirement for pain killers, and increase energy and activity levels.

REFERENCES:
patent: 4261980 (1981-04-01), Cort
patent: 5108754 (1992-04-01), Wilburn
patent: 5254572 (1993-10-01), Serfontein
patent: 5491150 (1996-02-01), Aoki et al.

Affiliated with

Also associated with

Rating

L-glutamine therapy for sickle cell diseases and thalassemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with L-glutamine therapy for sickle cell diseases and thalassemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and L-glutamine therapy for sickle cell diseases and thalassemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-801753